Gabapentin shows promise in treating refractory insomnia in children

Journal of Child Neurology

Volumn 28, Issue 12, 2013, Pages 1618-1621

  Robinson, Althea A ^a   Malow, Beth A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

gabapentin; insomnia; neurodevelopmental delay; sleep

Indexed keywords

GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADOLESCENT; ARTICLE; BEDTIME DOSAGE; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MALE; PEDIATRICS; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; INFANT; RETROSPECTIVE STUDY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADOLESCENT; AMINES; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MALE; POLYSOMNOGRAPHY; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84887929000     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812463069     Document Type: Article

References (11)

1. Owens JA, Babcock D, Blumer J, et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med. 2005 ; 1: 49-59
2. Robinson AM, Richdale AL. Sleep problems in children with an intellectual disability: parental perceptions of sleep problems, and views of treatment effectiveness. Child Care Health Dev. 2004 ; 30: 139-150
3. Owens JA. Update in pediatric sleep medicine. Curr Opin Pulm Med. 2011 ; 17: 425-430
4. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Topics Med Chem. 2005 ; 5: 3-14
5. Magnus L.. Nonepileptic uses of gabapentin.. Epilepsia 1999 ; 40 (suppl 6). S66 - S72
6. Lo HS, Yang CM, Lo HG, et al. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol. 2010 ; 33: 84-90
7. Salinsky MC, Storzbach D, Spencer DC, et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology. 2005 ; 64: 792-798
8. McLean MJ.. Clinical pharmacokinetics of gabapentin. Neurology. 1994 ; 44 (6 suppl 5). S17 - S22
9. Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011 ; 32: 939-962
10. Malow B, Adkins KW, McGrew SG, et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord. 2012 ; 42: 1729-1737
11. Andersen IM, Kaczmarska J, McGrew SG, Malow BA. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008 ; 23: 482-485